Applications of nanobiomaterials in the therapy and imaging of acute liver failure
Highlights This review focuses on the therapeutic mechanisms, targeting strategies of
various nanomaterials in acute liver failure, and recent advances of diverse nanomaterials …
various nanomaterials in acute liver failure, and recent advances of diverse nanomaterials …
[HTML][HTML] Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Overall, 12% of the global population (800 million) suffers from liver disease, which causes 2
million deaths every year. Liver injury involving characteristic reactive oxygen/nitrogen …
million deaths every year. Liver injury involving characteristic reactive oxygen/nitrogen …
Multifunctional nanohybrid based on porous silicon nanoparticles, gold nanoparticles, and acetalated dextran for liver regeneration and acute liver failure theranostics
Herein, a novel nanohybrid based on porous silicon, gold nanoparticles (Au NPs), and
acetalated dextran (DPSi/DAu@ AcDEX) is reported to encapsulate and deliver one drug …
acetalated dextran (DPSi/DAu@ AcDEX) is reported to encapsulate and deliver one drug …
Mesenchymal stem cell/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure
Acute liver failure is a critical condition characterized by global hepatocyte death and often
time needs a liver transplantation. Such treatment is largely limited by donor organ shortage …
time needs a liver transplantation. Such treatment is largely limited by donor organ shortage …
Nanotheranostics for the management of hepatic ischemia‐reperfusion injury
Hepatic ischemia‐reperfusion injury (IRI), in which an insufficient oxygen supply followed by
reperfusion leads to an inflammatory network and oxidative stress in disease tissue to cause …
reperfusion leads to an inflammatory network and oxidative stress in disease tissue to cause …
Diagnostic imaging and therapeutic application of nanoparticles targeting the liver
Liver diseases, particularly viral hepatitis, cirrhosis and hepatocellular carcinoma, are
common in clinical practice with high morbidity and mortality worldwide. Many substances …
common in clinical practice with high morbidity and mortality worldwide. Many substances …
[HTML][HTML] Therapeutic targeting of liver inflammation and fibrosis by nanomedicine
M Bartneck, KT Warzecha, F Tacke - Hepatobiliary surgery and …, 2014 - ncbi.nlm.nih.gov
Nanomedicine constitutes the emerging field of medical applications for nanotechnology
such as nanomaterial-based drug delivery systems. This technology may hold exceptional …
such as nanomaterial-based drug delivery systems. This technology may hold exceptional …
Nanomedicines in gastroenterology and hepatology
A Lamprecht - Nature Reviews Gastroenterology & Hepatology, 2015 - nature.com
Nanoscale systems are currently under investigation for multiple different diagnostic and
therapeutic applications. These systems can be used to identify pathologically changed …
therapeutic applications. These systems can be used to identify pathologically changed …
[HTML][HTML] Nanotechnology for therapy and imaging of liver diseases
LH Reddy, P Couvreur - Journal of hepatology, 2011 - Elsevier
Nanotechnology has been considered for the improved delivery of various therapeutic
agents, including drugs and genes. Indeed, liposomes and nanoparticles equipped with …
agents, including drugs and genes. Indeed, liposomes and nanoparticles equipped with …
The potential application of magnetic nanoparticles for liver fibrosis theranostics
A Eftekhari, A Arjmand, A Asheghvatan… - Frontiers in …, 2021 - frontiersin.org
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic liver
damage and leading to cirrhosis, liver cancer, and liver failure. To date, there is no effective …
damage and leading to cirrhosis, liver cancer, and liver failure. To date, there is no effective …